期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Medical Research Frontier. 2023; 7: (2) ; 27-29 ; DOI: 10.12208/j.imrf.20230019.

Root cause analysis and treatment of cross matching incompatibility in blood transfusion department
输血科交叉配血不符病例的根因分析及处置措施

作者: 赵新 *

北京市昌平区医院 北京

*通讯作者: 赵新,单位:北京市昌平区医院 北京;

发布时间: 2023-02-16 总浏览量: 314

摘要

目的 分析输血科交叉配血不符病例原因和解决方法。方法 选择2021年2月-2022年2月接收的50例患者为研究对象,将其收集的血液由同一医生进行离心处理和检查,分析引起交叉配血不符的原因,并制定解决方法。结果 不规则抗体、自身抗体、高效价冷抗体、ABO亚型例数分别为21、2、16、11。不规则抗体、自身抗体、高效价冷抗体、ABO亚型抗体阳性率分别为42%、4%、32%、22%。不规则抗体阳性率明显高于其他三种类型(P<0.05)为差异显著,有统计学意义。结论 输血科交叉配血不符病例最大原因为不规则抗体。所以患者输血治疗时需要根据血液检查结果选择最合适的配血方法,保证患者输血安全,保证输血效果。

关键词: 输血科;不规则抗体;高效价冷抗体;ABO亚型

Abstract

Objective To analyze the causes and solutions of cross matching incompatibility in blood transfusion department.
Methods 50 patients received from February 2021 to February 2022 were selected as the research objects, and the blood collected by them was centrifuged and examined by the same doctor. The causes of cross matching incompatibility were analyzed, and solutions were formulated.
Results The number of irregular antibody, autoantibody, high titer cold antibody and ABO subtype were 21, 2, 16 and 11, respectively. The positive rates of irregular antibody, autoantibody, high titer cold antibody and ABO subtype antibody were 42%, 4%, 32% and 22% respectively. The positive rate of irregular antibody was significantly higher than that of the other three types (P<0.05).
Conclusion   Irregular antibody is the biggest cause of cross matching incompatibility in blood transfusion department. Therefore, patients need to choose the most appropriate blood matching method according to the blood test results to ensure the safety of blood transfusion and the effect of blood transfusion.

Key words: Blood transfusion department; Irregular antibody; High titer cold antibody; ABO subtype

参考文献 References

[1] 陈扬,杜娟,李颖等.抗A_1抗体的血清学检测及其临床意义分析[J].细胞与分子免疫学杂志,2022,38(09):837-841.

[2] 张警丹,李鹏,李强等.抗CD38单克隆抗体对多发性骨髓瘤患者交叉配血干扰及输血疗效的影响[J].临床血液学杂志,2022,35(08):539-542.

[3] 张薇薇.ABO同型血交叉配血不合的影响因素及其处理对策[J].中国医药指南,2022,20(18):113-116.

[4] 张璐璐.微柱凝胶法交叉配血技术中供血者意外抗体筛查的临床应用效果[J].中国医药指南,2022,20(15):94-96.

[5] 韦庆成,隆耀清,黄波泰.多发性骨髓瘤患者ABO血型鉴定及交叉配血影响及对策[J].中国医学工程,2021,29(12):31-34.

[6] 张红军,张楠,陶松涛.微柱凝胶试验免疫检测技术在输血科交叉配血中的应用价值[J].河南医学研究,2021,30(30):5717-5719.

[7] 李森.ABO血型正反定型不符与交叉配血不合的原因及其处理方法[J].中国医药指南,2020,18(21):131-132.

[8] 孙春霞.疑难交叉配血产生的原因及意外抗体的分布特点[J].智慧健康,2020,6(16):68-70.

[9] 谢寒.自身免疫性溶血性贫血对血型鉴定及交叉配血结果的影响观察[J].临床医药文献电子杂志,2019,6(47):66-67.

[10] 党创伟,李自锋,刘钊锋,丁帅,周峰,李红娜,宋惠娜.新生儿ABO同型血交叉配血不合原因及安全输血分析[J].内科,2022,17(01):102-104.

[11] 张警丹,李鹏,李强,周雪丽.抗CD38单克隆抗体对多发性骨髓瘤患者交叉配血干扰及输血疗效的影响[J].临床血液学杂志,2022,35(08):539-542.

引用本文

赵新, 输血科交叉配血不符病例的根因分析及处置措施[J]. 国际医药研究前沿, 2023; 7: (2) : 27-29.